Literature DB >> 21785485

Pharmacology of opioids in the treatment of chronic pain syndromes.

Ricardo Vallejo1, Robert L Barkin, Victor C Wang.   

Abstract

The perpetual pursuit of pain elimination has been constant throughout human history and pervades human cultures. In some ways it is as old as medicine itself. Cultures throughout history have practiced the art of pain management through remedies such as oral ingestion of herbs or techniques believed to have special properties. In fact, even Hippocrates wrote about the practice of trepanation, the cutting of holes in the body to release pain. Current therapies for management of pain include the pervasive utilization of opioids, which have an extensive history, spanning centuries. There is general agreement about the appropriateness of opioids for the treatment of acute and cancer pain, but the long-term use of these drugs for treatment of chronic non-malignant pain remains controversial. The pros and cons regarding these issues are beyond the scope of this review. Instead, the purpose of this review will be directed towards the pharmacology of commonly prescribed opioids in the treatment of various chronic pain syndromes. Opium, derived from the Greek word for "juice," is extracted from the latex sap of the opium poppy (Papaverum somniferum). The juice of the poppy is the source of some 20 different alkaloids of opium. These alkaloids of opioids can be divided into 2 chemical classes: phenanthrenes (morphine, codeine, and thebaine) and benzylisoquinolines (agents that do not interact with opioid receptors).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785485

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  31 in total

1.  Peripheral nerve stimulation for trigeminal neuropathic pain.

Authors:  David A Stidd; Adam L Wuollet; Kirk Bowden; Theodore Price; Amol Patwardhan; Steve Barker; Martin E Weinand; Jeffrey Annabi; Emil Annabi
Journal:  Pain Physician       Date:  2012 Jan-Feb       Impact factor: 4.965

2.  Analyzing Analgesic Medications in Community-Dwelling Older Adults.

Authors:  Ann L Horgas; Urszula Snigurska; Michelle Z Farland; Michael Marsiske
Journal:  Pain Med       Date:  2019-01-01       Impact factor: 3.750

Review 3.  Management of the Cardiovascular Complications of Substance Use Disorders During Pregnancy.

Authors:  P Kaitlyn Edelson; Sarah N Bernstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-22

Review 4.  Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.

Authors:  Elyse M Cornett; Michelle A Carroll Turpin; Allison Pinner; Pankaj Thakur; Tamizh Selvan Gnana Sekaran; Harish Siddaiah; Jasmine Rivas; Anna Yates; G Jason Huang; Anitha Senthil; Narjeet Khurmi; Jenna L Miller; Cain W Stark; Richard D Urman; Alan David Kaye
Journal:  Curr Oncol Rep       Date:  2020-02-06       Impact factor: 5.075

Review 5.  Differences between opioids: pharmacological, experimental, clinical and economical perspectives.

Authors:  Asbjørn M Drewes; Rasmus D Jensen; Lecia M Nielsen; Joanne Droney; Lona L Christrup; Lars Arendt-Nielsen; Julia Riley; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 6.  Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering.

Authors:  Steven P Stanos; Patricia Bruckenthal; Robert L Barkin
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

Review 7.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

Review 9.  The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Authors:  Eric L Garland; Brett Froeliger; Fadel Zeidan; Kaitlyn Partin; Matthew O Howard
Journal:  Neurosci Biobehav Rev       Date:  2013-08-26       Impact factor: 8.989

10.  Tyr1-ψ[( Z)CF═CH]-Gly2 Fluorinated Peptidomimetic Improves Distribution and Metabolism Properties of Leu-Enkephalin.

Authors:  Ryan A Altman; Krishna K Sharma; Lian G Rajewski; Paul C Toren; Michael J Baltezor; Mohan Pal; Somnath N Karad
Journal:  ACS Chem Neurosci       Date:  2018-04-19       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.